Enantioselective immunorecognition of protein modification with optically active ibuprofen using polyclonal antibody

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 806, Issue 1, 2004, Pages 11-17

  Ito, Hiromi ^a   Ishiwata, Shunji ^a   Kosaka, Takeshi ^a   Nakashima, Rika ^a   Takeshita, Harunori ^a   Negoro, Sakiko ^a   Maeda, Masako ^b   Ikegawa, Shigeo ^a  

^a KINKI UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY   (Japan)

Author keywords

Ibuprofen; Immunorecognition; Polyclonal antibodies; Protein modification

Indexed keywords

AMINO ACIDS; DRUG PRODUCTS; ENZYMES; IMMUNOLOGY; LIVING SYSTEMS STUDIES; STEREOCHEMISTRY; TOXICITY;

CELLULAR PROTEINS; ENANTIOSELECTIVITY; IMMUNORECOGNITION; PROTEIN MODIFICATION;

ANTIBODIES;

4 AMINOBUTYRIC ACID; ANTIGEN; BOVINE SERUM ALBUMIN; ESTER DERIVATIVE; GLYCINE; IBUPROFEN; LYSINE DERIVATIVE; N ALPHA (TERT BUTOXYCARBONYL) EPSILON IBUPROFENYLLYSINE; PEPTIDE; POLYCLONAL ANTIBODY; TAURINE; UNCLASSIFIED DRUG;

BIOLOGICAL MONITORING; CHEMICAL MODIFICATION; CONFERENCE PAPER; COVALENT BOND; CROSS REACTION; DRUG CONJUGATION; ENANTIOSELECTIVITY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN MODIFICATION; RABBIT;

AMINO ACID SEQUENCE; ANTIBODIES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IBUPROFEN; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR SEQUENCE DATA; PROTEINS; STEREOISOMERISM;

BOVINAE; ORYCTOLAGUS CUNICULUS;

EID: 2442558061     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2004.01.040     Document Type: Conference Paper

References (26)

1. Hall S.D., Xiaoato Q. Chem.-Biol. Interact. 90:1994;235
2. Spahn-Langguth H., Benet L.Z. Drug Metab. Rev. 24:1992;5
3. Hayball P.J. Chirality. 7:1995;1
4. Ritter J.K. Chem.-Biol. Interact. 129:2000;171
5. Smith P.C., Song W., Rodriguez R.J. Drug Metab. Dispos. 20:1992;962
6. Bradow G., Kan L.S., Fenselau C. Chem. Res. Toxicol. 2:1989;316
7. King A.R., Dickinson R.G. Biochem. Pharmacol. 42:1991;2289
8. C. Fenselau, in: F.C. Kauffinan (Ed.), Conjugation-Deconjugation Reactions in Drug Metabolism, Toxicity, Springer-Verlag, Berlin, 1994, p. 367.
9. Smith P.C., Benet L.Z., McDonagh A.F. Drug. Metab. Dispos. 18:1990;639
10. Weiss J.S., Guatam A., Lauff J.J., Sundberg M.W., Jatlow P., Boyer J.L., Saligson D. N. Eng. J. Med. 309:1983;147
11. Ruelius H.W., Young E.M., Kirkman S.K., Schillings R.T., Sisenwine S.F., Janssen F.W. Biochem. Pharmacol. 34:1985;451
12. Faed E.M. Drug Metab. Rev. 15:1984;213
13. Smith P.C., MacDohagh A.F., Benet L.Z. J. Clin. Invest. 77:1986;934
14. Hargus S.J., Amouzedeh H.R., Pumford N.R., Myers T.G., McCoy S.C., Pohl L.R. Chem. Res. Toxicol. 7:1994;575
15. Krez-Rommel A., Boelsterli U.A. Mol. Pharmacol. 45:1994;237
16. Hinson J.A., Pumford N.R., Roberts D.W. Drug Metab. Rev. 27:1995;73
17. Martin J.L., Meinwald J., Radford P., Liu Z., Graf M.L., Pohl L.R. Drug Metab. Rev. 27:1995;179
18. Marco M.P., Nasiri M., Kurth M.J., Hammock B.D. Chem. Res. Toxicol. 6:1993;284
19. Cho M., Jedrychowski R., Hammock B.D., Buckpitt A.R. Fundam. Appl. Toxicol. 22:1994;26
20. Ikegawa S., Isriyanthi N.M.R., Nagata M., Yahata K., Ito H., Mano N., Goto J. Anal. Biochem. 296:2001;63
21. Moelhi M.E.L., Ruelius H.W., Fenselau C., Dulik D.M. Drug Metab. Dispos. 15:1987;767
22. Ikegawa S., Murao H., Oohashi J., Goto J. Biomed. Chromatogr. 12:1998;317
23. Lee E.J.D., Milliams R., Day R., Graham G., Champion D. J. Clin. Pharmacol. 19:1985;669
24. Ikegawa S., Matsuura K., Sato T., Isriyanthi N.M.R., Niwa T., Miyairi S., Takashina H., Kawashima Y., Goto J. J. Pharm. Biomed. Anal. 17:1998;1
25. Wang L., Chorev M., Feingers J., Levitzki A., Inbar M. FEBS Lett. 199:1986;173
26. Grafe K.A., Hoffmann H. Pharmazie. 55:2000;286